BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/88/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 01:52:40 2024-06-27 pm EDT | ||
| 0.25 EUR | -16.67% |
|
| Current month | -43.40% | ||
| 1 month | -33.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.25 | -16.67% |
| 24-06-26 | 0.3 | -9.09% |
| 24-06-25 | 0.33 | +3.13% |
| 24-06-24 | 0.32 | -11.11% |
| 24-06-21 | 0.36 | -5.26% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 01:52 pm EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM9ZGQ |
| ISIN | DE000VM9ZGQ9 |
| Date issued | 2024-02-07 |
| Strike | 88 $ |
| Maturity | 2024-09-20 (85 Days) |
| Parity | 10 : 1 |
| Emission price | 0.72 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.77 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.01 € |
| Spread % | 3.85% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.56
USD
Average target price
96.05
USD
Spread / Average Target
+4.91%
- Stock Market
- Warrants
- Warrant
